Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI
Crossref DOI link: https://doi.org/10.1007/s00234-014-1445-9
Published Online: 2014-10-07
Published Print: 2015-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lescher, Stephanie
Jurcoane, Alina
Veit, Andreas
Bähr, Oliver
Deichmann, Ralf
Hattingen, Elke
Text and Data Mining valid from 2014-10-07